Dr. Joe L. Mauderly
Inhalation Toxicology Laboratory
P.O. Box 5890
Albuquerque, NM 87185
Phone: 505-845-1124
Fax: 505-845-1193
Email: jmauderl@lrri.org
Projects are approved by an IRB located at: Lovelace Respiratory Research Institute.
The approving IRB operates under a Multiple Project Assurance (MPA) recognized by DOE or by the Department of Health and Human Services (HHS).
MPA number of the IRB: M-1479
Number of Human Subjects Projects reported: 1
Project Identifier: LRRI-95-IRB#95-030/IRB#96027
Project Title:
In Vivo Measurements of Lead-210 in Former Uranium Miners (formally ITRI-95-IRB#95-030/IRB#96027 in FY97 database)
Principal Investigator:
Dr. Raymond A. Guilmette
Project started in: 1995
Project Funding Information:
Project received funding in Fiscal Year 1998.
Project used human subjects in Fiscal Year 1998.
Funding Sources:
Project involves use of multiple protocols/subprojects.
Number of protocols/subprojects associated with this project: 1
Protocol/Subproject # 1
Protocol/Subproject Identifier: IRB#95-030/IRB#96027
IRB Review:
Type of Review: Expedited
Most Recent Approval: July 06, 1998
Number of Human Subjects who participated in this project/protocol during
FY 1998 (10/1/97 - 9/30/98): 121
Type of Human Subjects Involvement:
The hypothesis of these studies is that the measurement of lead-210 (210Pb) in the skeleton of uranium miners will provide an improved estimate of an individual miner's integrated exposure to radon (Rn).
Rn progeny decay to 210Pb. The lead locates in the skeleton of the individual who inhaled Rn. The amount of 210Pb in uranium miners is measured by using dual crystal scintillation detectors positioned around the head. The 210Pb is then calculated into working level months (WLM) using a standard biokinetic model.
There are no risks to the miners.
All miners are consented using an IRB approved consent form. Privacy and confidentiality are assured. No individual identifiers will be used in any publication resulting from the research.